Literature DB >> 19319452

The challenge of antiretroviral drug resistance in HIV-1-infected children.

Robert W Shafer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319452      PMCID: PMC4768743          DOI: 10.2223/JPED.1894

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


× No keyword cloud information.
  22 in total

1.  Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).

Authors:  Daisy Maria Machado; Silvana Cláudia Fernandes; Regina Célia de Menezes Succi; Wilton Santos Freire; Cláudio Sérgio Pannuti; Aída Barbosa Gouveia; José Eduardo Levi; Ricardo Sobie Diaz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2005-02-23       Impact factor: 1.846

Review 2.  HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  AIDS Rev       Date:  2008 Apr-Jun       Impact factor: 2.500

3.  Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Authors:  J C Couto-Fernandez; C Silva-de-Jesus; V G Veloso; M Rachid; R S G Gracie; S L Chequer-Fernandez; S M Oliveira; D Arakaki-Sanchez; P J N Chequer; M G Morgado
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-04-12       Impact factor: 2.743

4.  Selective pressures of human immunodeficiency virus type 1 (HIV-1) during pediatric infection.

Authors:  Elcio Leal; Mario Janini; Ricardo S Diaz
Journal:  Infect Genet Evol       Date:  2007-07-22       Impact factor: 3.342

5.  Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.

Authors:  Bart Janssens; Brian Raleigh; Seithaboth Soeung; Kazumi Akao; Vantha Te; Jitendra Gupta; Mean Chhy Vun; Nathan Ford; Janin Nouhin; Eric Nerrienet
Journal:  Pediatrics       Date:  2007-10-22       Impact factor: 7.124

6.  High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children.

Authors:  Moira Vignoles; Graciela Barboni; Maria Rosa Agosti; Jorge Quarleri; Mariel Karina García; Vera Giraudi; Silvia González Ayala; Horacio Salomón
Journal:  Antivir Ther       Date:  2007

7.  Prevalence of HIV type 1 drug resistance mutations in treatment-naïve and experienced patients from resource-limited settings with universal access to antiretroviral therapy: a survey in two small Brazilian cities.

Authors:  Walter A Eyer-Silva; José Carlos Couto-Fernandez; Carlos Silva-de-Jesus; Mariza G Morgado
Journal:  Mem Inst Oswaldo Cruz       Date:  2008-03       Impact factor: 2.743

Review 8.  Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.

Authors:  Dirceu B Greco; Mariangela Simão
Journal:  AIDS       Date:  2007-07       Impact factor: 4.177

9.  Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.

Authors:  Constance Delaugerre; Josiane Warszawski; Marie-Laure Chaix; Florence Veber; Eugenia Macassa; Florence Buseyne; Christine Rouzioux; Stéphane Blanche
Journal:  J Med Virol       Date:  2007-09       Impact factor: 2.327

10.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.